Picture of Sapporo Clinical Laboratory logo

9776 — Sapporo Clinical Laboratory News Story

0.000.00%
jp flag iconLast trade - 00:00
Consumer DefensivesBalancedMicro CapSuper Stock

Table: Sapporo Clinical Lab -6-MTH group results

Nov 11 (Reuters)-  
             Sapporo Clinical Laboratory Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 6 months ended      6 months ended       Year to  
                Sep 30, 2016        Sep 30, 2015     Mar 31, 2017  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             8.43                8.60             17.69     
                 (-1.9 pct)          (+3.6 pct)       (+0.9 pct)   
  Operating        350 mln             501 mln          697 mln    
                 (-30.1 pct)         (+32.5 pct)      (-28.4 pct)  
  Recurring        370 mln             511 mln          727 mln    
                 (-27.6 pct)         (+29.8 pct)      (-27.3 pct)  
  Net              239 mln             320 mln          476 mln    
                 (-25.2 pct)         (+36.3 pct)      (-19.4 pct)  
  EPS             68.84 yen           92.04 yen       136.85 yen   
  Ann Div                             11.00 yen        11.00 yen   
  -Q2 div            NIL                 NIL                       
  -Q4 div                             11.00 yen        11.00 yen   
   
  NOTE - Sapporo Clinical Laboratory Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T  
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Sapporo Clinical Laboratory

See all news